BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.18
+0.12 (1.49%)
Oct 24, 2024, 4:00 PM EDT - Market closed
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of $1.69 billion as of October 24, 2024. Its market cap has increased by 39.54% in one year.
Market Cap
1.69B
Enterprise Value
2.25B
1-Year Change
39.54%
Ranking
Category
Stock Price
$8.18
Market Cap Chart
Since December 1, 1998, BioCryst Pharmaceuticals's market cap has increased from $100.40M to $1.69B, an increase of 1,585.58%. That is a compound annual growth rate of 11.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 23, 2024 | 1.67B | 35.92% |
Dec 29, 2023 | 1.23B | -42.68% |
Dec 30, 2022 | 2.14B | -14.12% |
Dec 31, 2021 | 2.49B | 89.46% |
Dec 31, 2020 | 1.32B | 245.25% |
Dec 31, 2019 | 381.00M | -56.94% |
Dec 31, 2018 | 884.80M | 83.11% |
Dec 29, 2017 | 483.20M | 3.49% |
Dec 30, 2016 | 466.90M | -38.31% |
Dec 31, 2015 | 756.80M | -13.40% |
Dec 31, 2014 | 873.90M | 94.59% |
Dec 31, 2013 | 449.10M | 522.02% |
Dec 31, 2012 | 72.20M | -35.36% |
Dec 30, 2011 | 111.70M | -51.92% |
Dec 31, 2010 | 232.30M | -7.38% |
Dec 31, 2009 | 250.80M | 378.63% |
Dec 31, 2008 | 52.40M | -77.65% |
Dec 31, 2007 | 234.50M | -30.60% |
Dec 29, 2006 | 337.90M | -23.72% |
Dec 30, 2005 | 443.00M | 252.71% |
Dec 31, 2004 | 125.60M | 3.37% |
Dec 31, 2003 | 121.50M | 614.71% |
Dec 31, 2002 | 17.00M | -75.61% |
Dec 31, 2001 | 69.70M | -40.02% |
Dec 29, 2000 | 116.20M | -74.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NovoCure | 1.75B |
Spyre Therapeutics | 1.74B |
NewAmsterdam Pharma Company | 1.70B |
NeoGenomics | 1.69B |
Immunocore Holdings | 1.67B |
Syndax Pharmaceuticals | 1.63B |
ARS Pharmaceuticals | 1.63B |
Novavax | 1.62B |